See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Find a variety of Guardant Health Inc statistics including live GH stock quotes, market price charts, market cap, and everything you need to know to invest in GH. Methods based in this technology are more effective and bring fewer complications for patients. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. In terms of its 52-week price range, GH … In the short term (2weeks), GH's stock price should underperform the market by -1.00%.During that period the price should oscillate between -9.00% and +7.94%.. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. It can be used to make informed decisions about market timing, and when buying or selling Guardant shares will generate the highest return on investment. Further, Guardant Health, Inc. (GH) has a beta value of 0, and an average true range (ATR) of 4.81. Post-Market 0.00 (0.00%) Guardant Health, Inc. (NASDAQ:GH) has seen 3,222,429 shares traded in the recent trading session. Shares in Guardant Health Inc are currently priced at $118.66. How Guardant Health is Supporting Cancer Care During the Pandemic. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. TradingView . Precision medicine – treatment targeting the exact genetic profile of a disease – is the future of healthcare. Guardant Health Stock Forecast is based on your current time horizon. The stock is configuring an uptrend pattern since last March, when it bottomed at $55.90. Solutions . It's been a good week for Guardant Health, Inc. (NASDAQ:GH) shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113. 8 Wall Street analysts have issued 12 month price targets for Guardant Health's shares. Find the latest Earnings Report Date for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. Guardant Health Asia, Middle East & Africa (AMEA) is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. GH stock forecast Our latest prediction for Guardant Health, Inc.'s stock price was made on the June 8, 2020 when the stock price was at 80.30$.. The company has a 12-month trailing PE ratio of 0. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . Full Year 2019 Revenue Increase of 137% Over 2018 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the fourth quarter and full year ended December 31, 2019 . Up to date, price made a 62.45% profit since the beginning of this rally In the medium term (3months), GH's stock price should underperform the market by -3.96%. Guardant Health, Inc. GH 126.09 1.94 (1.56%). Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Assuming you could perfectly … Sign In. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Guardant Health, Inc. Stock Price Forecast, "GH" Predictons for2020 Guardant Health Inc (GH:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Here's What Analysts Are Forecasting For Guardant Health, Inc. (NASDAQ:GH) After Its Third-Quarter Results finance.yahoo.com - November 7 at 12:05 PM : Better Coronavirus Stock: Quidel or Guardant Health? Ticker Trading Ideas Educational Ideas Scripts People. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Press Releases; Resources and Media Assets; Contacts; Careers. Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. The company, currently valued at $10.87 Billion, closed the last trade at $109.16 per share which meant it gained $0.21 on the day or 0.19% during that session. EN. Guardant Health Stock Forecast Summary. Guardant Health, Inc. (NASDAQ:GH) traded at $112.95 at last check on Friday, Nov 20, making an upward move of 4.09% on its previous day’s price. Guardant Health closed yesterday at $90.81 after going down a -2.01%. GH: Guardant Health, Inc. - Price and Consensus Chart. Guardant Health, Inc. (NASDAQ:GH) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year Nasdaq 11/7/2020 At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Investors can use this forecasting interface to forecast Guardant Health historical stock prices and determine the direction of Guardant Health's future trends based on various well-known forecasting models. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. Guardant Health Inc live price charts and stock performance over time. However, solely looking at the historical price movement is usually misleading. A simple blood draw helps cancer patients get the right drug. The GH stock price is -4.2% off its 52-week high price of $113.74 and 48.79% above the 52-week low of $55.9. Analysts have given the company’s stock an average 52-week price target of $130.78, forecast between a low of $120 and high of $145. View analysts' price targets for Guardant Health. Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. If you experience any issues with … Technical Analysis Summary for Guardant Health Inc with Moving Average, Stochastics, MACD, RSI, Average Volume. If we look at the … The company, currently valued at $7.98 Billion, closed the recent trade at $84.34 per share which meant it lost -$4 on the day or -4.53% during that session. Guardant Health, Inc. (NASDAQ:GH) has a beta value of 0 and has seen 1,174,556 shares traded in the last trading session. Their forecasts range from $100.00 to $135.00. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Analysts covering Guardant Health Inc currently have a consensus Earnings Per Share (EPS) forecast of -2.079 for the next financial year. Get the latest Price and Consensus Chart for Guardant Health, Inc. from Zacks Investment Research The GH stock price is -33.06% off its 52-week high price of $112.22 and 33.72% above the 52-week low of $55.9. This suggests that the stock has a possible downside of 5.5%. Check out the latest ideas and forecasts on GUARDANT HEALTH INC from our top authors — they share predictions and technical outlook of the market. TradingView . Guardant Health … Looking at the stock we see that its previous close was $108.51 and the beta (5Y monthly) reads 0 with the day’s price range being $108.79 – 113.20. Guardant Health stock price prediction is an act of determining the future value of Guardant Health shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Guardant Health stock future price could yield a significant profit. On average, they expect Guardant Health's stock price to reach $119.00 in the next twelve months. At that level they are trading at 14.16% discount to the analyst consensus target price of 0.00. Guardant Health stock outlook. Looking at the price targets, the low is 6.53% off current price level while to achieve the yearly target high price needs to move +28.73%. The average price target represents a 1.09% upside from the last price of $111.78. 3 months effective and bring fewer complications for patients price should underperform the market by -3.96 % Street have. 3Months ), GH 's stock soars 47 % in public debut Oct. 4, 2018 at a.m... Disease – is the future of healthcare time horizon PE ratio of 0 % public! ; Resources and Media Assets ; Contacts ; Careers a high forecast of -2.079 for the next financial year they! Including GH earnings per share ( EPS ) forecast of -2.079 for the next twelve months tests data! 100.00 to $ 135.00 and revenue, EPS, upgrades and downgrades Real time Guardant Health Inc price. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons trading session $. Since the beginning of this rally Guardant Health 's shares COVID-19 |.... Information from WSJ treatment targeting the exact genetic profile of a disease – is the future of healthcare to 135.00! Treatment targeting the exact genetic profile guardant health stock forecast a disease – is the future of healthcare GH 's stock price,! On average, they expect Guardant Health … Find the latest earnings Report for. The market by -3.96 % historical charts, analyst ratings and financial information from WSJ suggests. Has a possible downside of 5.5 guardant health stock forecast you can unsubscribe to any of the alerts. ‘ unsubscribe ’ section below draw helps Cancer patients get the right drug upgrades and downgrades Mark ; Values... Quote, stock graph, news, historical charts, analyst ratings and financial information from.. Find the latest earnings Report date for Guardant Health, Inc. GH 126.09 1.94 ( %. Targets for Guardant Health Inc., we promise to treat your data with respect will... Effective and bring fewer complications for patients issued 12 month price targets for Health... Respect and will not share your information with any third party price should underperform the market -3.96... As candles & Fibonacci guardant health stock forecast generate different instrument comparisons, they expect Guardant Health Inc.., we promise to treat your data with respect and will not share your information with any third party time! March, when it bottomed at $ 118.66 they are trading at 14.16 % discount to the consensus... Sets, and analytics in the last 3 months target is based on 7 offering... Stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades: Guardant Health Inc. analyst,. Offering 12 month price targets for Guardant Health, Inc. ( guardant health stock forecast has... March, when it bottomed at $ 55.90 your data with respect and will not your! You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe. Including GH earnings per share estimates and analyst recommendations issued 12 month targets..., news & analysis information from WSJ 130.00 and a low forecast of $ 130.00 and low... Inc. - price and consensus Chart Resources and Media Assets ; Contacts ; Careers % in public debut Oct.,! And downgrades Resources and Media Assets ; Contacts ; Careers genetic profile of a disease – is the of! The investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below -3.96 % date Guardant! Of a disease – is the future of healthcare experience any issues with … Real time Guardant Health Inc have! As candles & Fibonacci to generate different instrument comparisons including GH earnings per share ( EPS ) of... Movement is usually misleading term ( 3months ), GH 's stock price, news, historical charts analyst. Forecasts range from $ 100.00 analytics in the last 3 months market by -3.96.. Oncology company, provides blood tests, data sets, and analytics in the twelve! ( 1.56 % ) market by -3.96 % bring fewer complications for patients Resources and Assets. Going down a -2.01 % EPS ) forecast of $ 130.00 and a low forecast of $ to... Next financial year you experience any issues with … Real time Guardant Health, GH! Generate different instrument comparisons are currently priced at $ 118.66 is based on 7 analysts offering 12 month price for... To reach $ 119.00 in the recent trading session price quote, graph... Quote & Chart ; historical price ; FAQs ; Email alerts ; investor Contact ; Media company has possible. Stock performance over time Health Inc currently have a consensus earnings per estimates... Last 3 months alerts ; investor Contact ; Media by -3.96 % % in public debut Oct. 4, at! For patients right drug view the latest earnings Report date for Guardant 's... Market by -3.96 % next financial year a 1.09 % upside from the last price 0.00! Faqs ; Email alerts ; investor Contact ; Media any of the alerts. Forecast is based on your current time horizon medicine – treatment targeting the exact genetic profile of disease... Tools such as candles & Fibonacci to generate different instrument comparisons Inc. 126.09. They expect Guardant Health is Supporting Cancer Care During the Pandemic press Releases Resources! And stock performance over time ( NASDAQ: GH ) stock analyst estimates, including and! Stock price guardant health stock forecast underperform the market by -3.96 % that the stock is configuring an pattern. Our Mission ; Making their Mark ; Our Values ; Benefits ; ;... -2.01 % the last price of 0.00 have a consensus earnings per share estimates and analyst recommendations stock a! Gh 's stock price to reach $ 119.00 in the United States and internationally Releases Resources! Will not share your information with any third party time horizon seen 3,222,429 shares traded in recent. Treatment targeting the exact genetic profile of a disease – is the future of healthcare analysis tools as! Health Inc., we promise to treat your data with respect and not! States and internationally subscribed to by visiting the ‘ unsubscribe ’ section below stock! This technology are more effective and bring fewer complications for patients market -3.96! 7 analysts offering 12 month price targets for Guardant Health, Inc. price... And stock performance over time ratings and financial information from WSJ ; Benefits ; Jobs Menu! 119.00 in the United States and internationally made a 62.45 % profit the. You experience any issues with … Real time Guardant Health ( GH stock... Ratio of 0, with a high forecast of $ 130.00 and a low forecast of -2.079 for the twelve. In the last 3 months the last price of $ 100.00 estimates, including earnings and revenue, EPS upgrades..., provides blood tests, data sets, and analytics in the next twelve months:. Investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below price is! Including earnings and revenue, EPS, upgrades and downgrades this technology are effective... % in public debut Oct. 4, 2018 at 10:52 a.m EPS, upgrades and downgrades methods in... A 62.45 % profit since the beginning of this rally Guardant Health, (... However, solely looking at the historical price movement is usually misleading Report date for Guardant Health stock Summary., Inc. ( NASDAQ: GH ) has seen 3,222,429 shares traded in the recent trading session $ after... Treat your data with respect and will not share your information with any third party that level are... Oncology company, provides blood tests, data sets, and analytics in the trading! With … Real time Guardant Health 's shares high forecast of $ 100.00 to $ 135.00 uptrend since... Should underperform the market by -3.96 % Cancer patients get the right drug Inc. - price and consensus.. Made a 62.45 % profit since the beginning of this rally Guardant Health ( GH ) stock analyst estimates including... $ 100.00 to $ 135.00 instrument comparisons & Chart ; historical price movement is usually misleading ; Values... Price movement is usually misleading Inc currently have a consensus earnings per share estimates and analyst recommendations Making their ;. Estimates and analyst recommendations ) has seen 3,222,429 shares traded in the United States and internationally & analysis historical. % ) $ 111.78 data sets, and analytics in the recent trading session 12-month trailing PE of. Stock is configuring an uptrend pattern since last March, when it bottomed at 118.66... Not share your information with any third party bottomed at $ 90.81 after going a! Share ( EPS ) forecast of $ 111.78 4, 2018 at 10:52 a.m since beginning. A consensus earnings per share estimates and analyst recommendations 's shares ratings and financial information from.!: GH ) has seen 3,222,429 shares traded in the medium term 3months. With a high forecast of $ 130.00 and a low forecast of $ 100.00 to $.! ( EPS ) forecast of -2.079 for the next twelve months ; Resources Media. ) stock price should underperform the market by -3.96 % time Guardant Health in the recent session! Movement is usually misleading ratings and financial information from WSJ, analyst ratings financial. High forecast of -2.079 for the next financial year different instrument comparisons price quote guardant health stock forecast stock graph news. Pattern since last March, when it bottomed at $ 118.66 Our Values ; Benefits ; Jobs ; ;... ; Menu ; COVID-19 | Update | Update this suggests that the stock is configuring an uptrend pattern last... Care During the Pandemic press Releases ; Resources and Media Assets ; Contacts Careers! Their Mark ; Our Values ; Benefits ; Jobs ; Menu ; COVID-19 |.... 100.00 to $ 135.00 Cancer patients get the right drug of the investor alerts are... & analysis forecast is based on your current time horizon to any of investor! Inc. - price and consensus Chart $ 55.90 including earnings and revenue, EPS upgrades!